Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer

Abstract

Cancer-associated fibroblasts (CAFs) are the vital constituent of the tumor microenvironment, and in communication with other cells, they contribute to tumor progression and metastasis. Fibroblasts are the proposed origin of CAFs, which are mediated by pro-inflammatory cytokines and the recruitment of immune cells akin to wound healing. Although various studies have identified different subpopulations of CAFs in lung cancer, the heterogeneity of CAFs, particularly in lung cancer, and their potential as a therapeutic target remain largely unknown. Notwithstanding CAFs were previously thought to have predominantly tumor-promoting features, their pro- or anti-tumorigenic properties may depend on various conditions and cell origins. The absence of distinct markers to identify CAF subpopulations presents obstacles to the successful therapeutic targeting and treatment of CAFs in cancer. Human clinical and animal studies targeting CAFs have shown that targeting CAFs exacerbates the disease progression, suggesting that subpopulations of CAFs may exert opposing functions in cancer progression. Therefore, it is essential to pinpoint specific markers capable of characterizing these subpopulations and revealing their mechanisms of function. The cell-specific surface markers of CAFs will serve as an initial step in investigating precise CAF subpopulations and their role in diagnosing and targeting therapy against cancer-promoting CAF subsets in lung cancer.

Keywords

Fibroblasts / lung cancer / inflammation / targeted therapy / therapeutic markers

References

[1] Sung H,Siegel RL.Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2021;71:209-49

[2] Ferone G,Sage J.Cells of origin of lung cancers: lessons from mouse studies.Genes Dev2020;34:1017-32 PMCID:PMC7397855

[3] Fidler-Benaoudia MM,Bray F,Jemal A.Lung cancer incidence in young women vs. young men: a systematic analysis in 40 countries.Int J Cancer2020;147:811-9

[4] Miller KD,Mariotto AB.Cancer treatment and survivorship statistics, 2019.CA Cancer J Clin2019;69:363-85

[5] Hanahan D.Accessories to the crime: functions of cells recruited to the tumor microenvironment.Cancer Cell2012;21:309-22

[6] Mahale J,Brown K,Howells LM.The role of stromal fibroblasts in lung carcinogenesis: a target for chemoprevention?.Int J Cancer2016;138:30-44

[7] Foster DS,Ransom RC,Norton JA.The evolving relationship of wound healing and tumor stroma.JCI Insight2018;3:99911 PMCID:PMC6237224

[8] Belhabib I,Lac C,Jean C.Extracellular matrices and cancer-associated fibroblasts: targets for cancer diagnosis and therapy?.Cancers2021;13:3466 PMCID:PMC8303391

[9] Chan TS,Tsai KK.Targeting the interplay between cancer fibroblasts, mesenchymal stem cells, and cancer stem cells in desmoplastic cancers.Front Oncol2019;9:688 PMCID:PMC6684765

[10] Miyazaki Y,Mori N.Adipose-derived mesenchymal stem cells differentiate into pancreatic cancer-associated fibroblasts in vitro.FEBS Open Bio2020;10:2268-81 PMCID:PMC7609785

[11] Shi Y,Lin L.Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets.Nat Rev Drug Discov2017;16:35-52

[12] Kalluri R.The biology and function of fibroblasts in cancer.Nat Rev Cancer2016;16:582-98

[13] Kojima Y,Eaton EN.Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts.Proc Natl Acad Sci U S A2010;107:20009-14 PMCID:PMC2993333

[14] Ren Y,Liu X.Reprogramming carcinoma associated fibroblasts by AC1MMYR2 impedes tumor metastasis and improves chemotherapy efficacy.Cancer Lett2016;374:96-106

[15] Tang PCT,Xue VWW.Smad3 promotes cancer-associated fibroblasts generation via macrophage-myofibroblast transition.Adv Sci2022;9:e2101235 PMCID:PMC8728853

[16] Glabman RA,Sato N.Cancer-associated fibroblasts: tumorigenicity and targeting for cancer therapy.Cancers2022;14:3906 PMCID:PMC9405783

[17] Saito A,Nagase T.TGF-β signaling in lung health and disease.Int J Mol Sci2018;19:2460 PMCID:PMC6121238

[18] Navab R,Bandarchi B.Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer.Proc Natl Acad Sci U S A2011;108:7160-5 PMCID:PMC3084093

[19] Neri S,Hashimoto H.Fibroblast-led cancer cell invasion is activated by epithelial-mesenchymal transition through platelet-derived growth factor BB secretion of lung adenocarcinoma.Cancer Lett2017;395:20-30

[20] Liu Y,Wang X.Effect of chronic intermittent hypoxia on biological behavior and hypoxia-associated gene expression in lung cancer cells.J Cell Biochem2010;111:554-63

[21] Zhang Y,Wang Y.HIF-1α is necessary for activation and tumour-promotion effect of cancer-associated fibroblasts in lung cancer.J Cell Mol Med2021;25:5457-69 PMCID:PMC8184678

[22] Özdemir BC,Carstens JL.Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.Cancer Cell2014;25:719-34 PMCID:PMC4180632

[23] Rhim AD,Thomas DH.Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.Cancer Cell2014;25:735-47 PMCID:PMC4096698

[24] Amakye D,Dorsch M.Unraveling the therapeutic potential of the hedgehog pathway in cancer.Nat Med2013;19:1410-22

[25] Li Z,Zhang J,Wang H.Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5.Int J Cancer2019;145:1946-57 PMCID:PMC6767568

[26] Turley SJ,Astarita JL.Immunological hallmarks of stromal cells in the tumour microenvironment.Nat Rev Immunol2015;15:669-82

[27] Ziani L,Thiery J.Alteration of the antitumor immune response by cancer-associated fibroblasts.Front Immunol2018;9:414 PMCID:PMC5837994

[28] Arnold JN,Kraman M.Tumoral immune suppression by macrophages expressing fibroblast activation protein-α and heme oxygenase-1.Cancer Immunol Res2014;2:121-6 PMCID:PMC4007628

[29] Yang X,Shi Y.FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling.Cancer Res2016;76:4124-35

[30] Kobayashi H,Woods SL,Takahashi M.Cancer-associated fibroblasts in gastrointestinal cancer.Nat Rev Gastroenterol Hepatol2019;16:282-95

[31] Zhang J,Liu X,Blankenstein T.Fibroblast-specific protein 1/S100A4-positive cells prevent carcinoma through collagen production and encapsulation of carcinogens.Cancer Res2013;73:2770-81

[32] Astarita JL,Turley SJ.Podoplanin: emerging functions in development, the immune system, and cancer.Front Immunol2012;3:283 PMCID:PMC3439854

[33] Krishnan H,Miyashita T.Podoplanin: an emerging cancer biomarker and therapeutic target.Cancer Sci2018;109:1292-9 PMCID:PMC5980289

[34] Vázquez-Villa F,Galván JA.COL11A1/(pro)collagen 11A1 expression is a remarkable biomarker of human invasive carcinoma-associated stromal cells and carcinoma progression.Tumour Biol2015;36:2213-22

[35] Jia D,Deng N.A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets.Cancer Lett2016;382:203-14 PMCID:PMC5077659

[36] Nishishita R,Seino H.Expression of cancer-associated fibroblast markers in advanced colorectal cancer.Oncol Lett2018;15:6195-202 PMCID:PMC5876461

[37] Yu Y,Tan LD,Li XQ.Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling.Br J Cancer2014;110:724-32 PMCID:PMC3915130

[38] Nurmik M,Rodriguez F,Letellier E.In search of definitions: cancer-associated fibroblasts and their markers.Int J Cancer2020;146:895-905 PMCID:PMC6972582

[39] Martínez-Nieto GA,Petrelius N.Upregulated integrin α11 in the stroma of cutaneous squamous cell carcinoma promotes skin carcinogenesis.Front Oncol2022;12:981009 PMCID:PMC9393502

[40] Zeltz C,Heljasvaara R.Integrin α11β1 in tumor fibrosis: more than just another cancer-associated fibroblast biomarker?.J Cell Commun Signal2022;16:649-60 PMCID:PMC8978763

[41] Zeltz C,Liu H.α11β1 Integrin is induced in a subset of cancer-associated fibroblasts in desmoplastic tumor stroma and mediates in vitro cell migration.Cancers2019;11:765 PMCID:PMC6627481

[42] Hu G,Zhong K.PDGFR-β⁺ fibroblasts deteriorate survival in human solid tumors: a meta-analysis.Aging2021;13:13693-707 PMCID:PMC8202854

[43] Yoon H,Banerjee S.Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis.Oncogene2021;40:1957-73 PMCID:PMC7979540

[44] Su S,Yao H.CD10⁺GPR77⁺ cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness.Cell2018;172:841-56.e16

[45] Tong Y,Zhang J,Zhu Y.High expressions of CD10, FAP and GPR77 in CAFs are associated with chemoresistance and worse prognosis in gastric cancer.Front Oncol2022;12:984817 PMCID:PMC9650088

[46] Katoh D,Noro A,Imanaka-Yoshida K.Tenascin-C induces phenotypic changes in fibroblasts to myofibroblasts with high contractility through the integrin αvβ1/transforming growth factor β/SMAD signaling axis in human breast cancer.Am J Pathol2020;190:2123-35

[47] Ni WD,Cui CA,Fang LY.Tenascin-C is a potential cancer-associated fibroblasts marker and predicts poor prognosis in prostate cancer.Biochem Biophys Res Commun2017;486:607-12

[48] Hashimoto M,Osakabe M.Expression patterns of microenvironmental factors and tenascin-C at the invasive front of stage II and III colorectal cancer: novel tumor prognostic markers.Front Oncol2021;11:690816 PMCID:PMC8417423

[49] Le PN,Miller B.Wnt signaling dynamics in head and neck squamous cell cancer tumor-stroma interactions.Mol Carcinog2019;58:398-410 PMCID:PMC6460915

[50] Qin X,Zhang J.TGFβ3-mediated induction of periostin facilitates head and neck cancer growth and is associated with metastasis.Sci Rep2016;6:20587 PMCID:PMC4746667

[51] Chen D.Value of caveolin-1 in cancer progression and prognosis: emphasis on cancer-associated fibroblasts, human cancer cells and mechanism of caveolin-1 expression (review).Oncol Lett2014;8:1409-21 PMCID:PMC4156192

[52] Shimizu K,Aokage K.Clinicopathological significance of caveolin-1 expression by cancer-associated fibroblasts in lung adenocarcinoma.J Cancer Res Clin Oncol2017;143:321-8

[53] Shi X,Zhou H.Transforming growth factor-β signaling in fibrotic diseases and cancer-associated fibroblasts.Biomolecules2020;10:1666 PMCID:PMC7763058

[54] Erdogan B.Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis.Biochem Soc Trans2017;45:229-36 PMCID:PMC5371349

[55] Hassan M,Risse PA.Airway smooth muscle remodeling is a dynamic process in severe long-standing asthma.J Allergy Clin Immunol2010;125:1037-45.e3

[56] Chen Y,Zhang Y.Transforming growth factor-β1 and α-smooth muscle actin in stromal fibroblasts are associated with a poor prognosis in patients with clinical stage I-IIIA nonsmall cell lung cancer after curative resection.Tumour Biol2014;35:6707-13

[57] Alcaraz J,Millares L.Stromal markers of activated tumor associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer.Lung Cancer2019;135:151-60

[58] Kilvaer TK,Hellevik T.Cancer associated fibroblasts in stage I-IIIA NSCLC: prognostic impact and their correlations with tumor molecular markers.PLoS One2015;10:e0134965 PMCID:PMC4529239

[59] Kieffer Y,Gentric G.Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer.Cancer Discov2020;10:1330-51

[60] Feig C,Kraman M.Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.Proc Natl Acad Sci U S A2013;110:20212-7 PMCID:PMC3864274

[61] Scanlan MJ,Calvo B.Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers.Proc Natl Acad Sci U S A1994;91:5657-61 PMCID:PMC44055

[62] Shi X,Weigel KJ.Cancer-associated fibroblasts facilitate squamous cell carcinoma lung metastasis in mice by providing TGFβ-mediated cancer stem cell niche.Front Cell Dev Biol2021;9:668164 PMCID:PMC8435687

[63] Santos AM,Aziz N,Puré E.Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.J Clin Invest2009;119:3613-25 PMCID:PMC2786791

[64] Jia J,Ye L.Fibroblast activation protein-α promotes the growth and migration of lung cancer cells via the PI3K and sonic hedgehog pathways.Int J Mol Med2018;41:275-83 PMCID:PMC5746330

[65] Liao Y,He R,Du J.Clinical implications of fibroblast activation protein-α in non-small cell lung cancer after curative resection: a new predictor for prognosis.J Cancer Res Clin Oncol2013;139:1523-8

[66] Coto-Llerena M,Kancherla V.High expression of FAP in colorectal cancer is associated with angiogenesis and immunoregulation processes.Front Oncol2020;10:979 PMCID:PMC7362758

[67] Wang LC,Scholler J.Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity.Cancer Immunol Res2014;2:154-66 PMCID:PMC4007316

[68] Kilvaer TK,Hellevik T.Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer.PLoS One2018;13:e0192157 PMCID:PMC5802915

[69] Loeffler M,Niethammer AG.Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake.J Clin Invest2006;116:1955-62 PMCID:PMC1481657

[70] Shen W,Hao F.S100A4 expression is associated with poor prognosis in patients with resectable gastrointestinal stromal tumor.Libyan J Med2019;14:1659669 PMCID:PMC6735325

[71] Destek S.S100A4 may be a good prognostic marker and a therapeutic target for colon cancer.J Oncol2018;2018:1828791 PMCID:PMC6077577

[72] Stewart RL,West DS.S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide.Oncotarget2016;7:34630-42 PMCID:PMC5085181

[73] Zhang J,Liu X,Huang G.Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.Biosci Rep2020;40:BSR20201710 PMCID:PMC7396424

[74] Sun X.Cancer-associated fibroblast-derived CCL5 contributes to cisplatin resistance in A549 NSCLC cells partially through upregulation of lncRNA HOTAIR expression.Oncol Lett2021;22:696 PMCID:PMC8358620

[75] Qi R,Zhuang X.Small interfering RNA targeting S100A4 sensitizes non-small-cell lung cancer cells (A549) to radiation treatment.Onco Targets Ther2016;9:3753-62 PMCID:PMC4922784

[76] Hou S,Qi D.S100A4 promotes lung tumor development through β-catenin pathway-mediated autophagy inhibition.Cell Death Dis2018;9:277 PMCID:PMC5833421

[77] Neri S,Hashimoto H.Podoplanin-expressing cancer-associated fibroblasts lead and enhance the local invasion of cancer cells in lung adenocarcinoma.Int J Cancer2015;137:784-96

[78] Hesse K,Schacht V.Characterisation of prognosis and invasion of cutaneous squamous cell carcinoma by podoplanin and E-cadherin expression.Dermatology2016;232:558-65

[79] Hoshino A,Ito T.Podoplanin-positive fibroblasts enhance lung adenocarcinoma tumor formation: podoplanin in fibroblast functions for tumor progression.Cancer Res2011;71:4769-79

[80] Suzuki J,Neri S.Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma.Lung Cancer2021;153:1-10

[81] Ito M,Nagai K,Nakano Y.Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma.Chest2012;142:151-8

[82] Kawase A,Nagai K.Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma.Int J Cancer2008;123:1053-9

[83] Koriyama H,Yoh K.Presence of podoplanin-positive cancer-associated fibroblasts in surgically resected primary lung adenocarcinoma predicts a shorter progression-free survival period in patients with recurrences who received platinum-based chemotherapy.J Cancer Res Clin Oncol2015;141:1163-70

[84] Ono S,Nagai K.Podoplanin-positive cancer-associated fibroblasts could have prognostic value independent of cancer cell phenotype in stage I lung squamous cell carcinoma: usefulness of combining analysis of both cancer cell phenotype and cancer-associated fibroblast phenotype.Chest2013;143:963-70

[85] Hu G,Xu F.Tumor-infiltrating podoplanin+ fibroblasts predict worse outcome in solid tumors.Cell Physiol Biochem2018;51:1041-50

[86] Yoshida T,Goto K.Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation.Clin Cancer Res2015;21:642-51

[87] Sugiura H,Liu X.N-acetyl-L-cysteine inhibits TGF-β₁-induced profibrotic responses in fibroblasts.Pulm Pharmacol Ther2009;22:487-91

[88] Biernacka A,Frangogiannis NG.TGF-β signaling in fibrosis.Growth Factors2011;29:196-202 PMCID:PMC4408550

[89] Zhu CQ,Brown ERS.Integrin α 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.Proc Natl Acad Sci U S A2007;104:11754-9 PMCID:PMC1913903

[90] Wang KK,Radulovich N.Novel candidate tumor marker genes for lung adenocarcinoma.Oncogene2002;21:7598-604

[91] Navab R,To C.Integrin α11β1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer.Oncogene2016;35:1899-908 PMCID:PMC4833874

[92] Zhang Q,Evans BJ,Weroha SJ.LY2157299 monohydrate, a TGF-βR1 inhibitor, suppresses tumor growth and ascites development in ovarian cancer.Cancers2018;10:260 PMCID:PMC6115954

[93] Carracedo S,Popova SN,Eckes B.The fibroblast integrin α11β1 is induced in a mechanosensitive manner involving activin A and regulates myofibroblast differentiation.J Biol Chem2010;285:10434-45 PMCID:PMC2856250

[94] Honda E,Munakata H.Transforming growth factor-beta upregulates the expression of integrin and related proteins in MRC-5 human myofibroblasts.Tohoku J Exp Med2010;220:319-27

[95] Iwai M,Togo S.Cancer-associated fibroblast migration in non-small cell lung cancers is modulated by increased integrin α11 expression.Mol Oncol2021;15:1507-27 PMCID:PMC8096795

[96] Lu N,Ranta J,Soininen R.The human alpha11 integrin promoter drives fibroblast-restricted expression in vivo and is regulated by TGF-beta1 in a Smad- and Sp1-dependent manner.Matrix Biol2010;29:166-76

[97] Talior-Volodarsky I,Arora PD,McCulloch CA.α11 integrin stimulates myofibroblast differentiation in diabetic cardiomyopathy.Cardiovasc Res2012;96:265-75

[98] Siegel RL,Jemal A.Cancer statistics, 2019.CA Cancer J Clin2019;69:7-34

[99] Dauphin M,Lemaire S.Vimentin expression predicts the occurrence of metastases in non small cell lung carcinomas.Lung Cancer2013;81:117-22

[100] Burch TC,Nyalwidhe JO.Variable metastatic potentials correlate with differential plectin and vimentin expression in syngeneic androgen independent prostate cancer cells.PLoS One2013;8:e65005 PMCID:PMC3661497

[101] Chen Z,Ma J.Regulatory mechanisms and clinical significance of vimentin in breast cancer.Biomed Pharmacother2021;133:111068

[102] Richardson AM,Koyen AE.Vimentin is required for lung adenocarcinoma metastasis via heterotypic tumor cell-cancer-associated fibroblast interactions during collective invasion.Clin Cancer Res2018;24:420-32 PMCID:PMC5771825

[103] Wang L,Wang H.Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6/STAT3 signaling pathway.Oncotarget2017;8:76116-28 PMCID:PMC5652691

[104] Zou X,Qu ZY.Targeting the PDGF/PDGFR signaling pathway for cancer therapy: a review.Int J Biol Macromol2022;202:539-57

[105] Masoumi J,Khorramdelazad H,Abdolalizadeh J.Role of Apelin/APJ axis in cancer development and progression.Adv Med Sci2020;65:202-13

[106] Donnem T,Al-Shibli K,Busund LT.Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells.J Thorac Oncol2008;3:963-70

[107] Tejada ML,Dong J.Tumor-driven paracrine platelet-derived growth factor receptor alpha signaling is a key determinant of stromal cell recruitment in a model of human lung carcinoma.Clin Cancer Res2006;12:2676-88

[108] Laing N,Wen S.Inhibition of platelet-derived growth factor receptor α by MEDI-575 reduces tumor growth and stromal fibroblast content in a model of non-small cell lung cancer.Mol Pharmacol2013;83:1247-56

[109] Jones RL.The development and application of imatinib.Expert Opin Drug Saf2005;4:183-91

[110] Kinoshita K,Hamada JI.Imatinib mesylate inhibits the proliferation-stimulating effect of human lung cancer-associated stromal fibroblasts on lung cancer cells.Int J Oncol2010;37:869-77

[111] Haubeiss S,Mürdter TE.Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts.Mol Cancer2010;9:168 PMCID:PMC2907332

[112] Liu JQ,Zhu J,Talebian F.CD200-CD200R pathway in the regulation of tumor immune microenvironment and immunotherapy.Adv Exp Med Biol2020;1223:155-65 PMCID:PMC7339106

[113] Kotwica-Mojzych K,Mojzych M.CD200:CD200R interactions and their importance in immunoregulation.Int J Mol Sci2021;22:1602 PMCID:PMC7915401

[114] Ishibashi M,Hashimoto H.CD200-positive cancer associated fibroblasts augment the sensitivity of epidermal growth factor receptor mutation-positive lung adenocarcinomas to EGFR tyrosine kinase inhibitors.Sci Rep2017;7:46662 PMCID:PMC5399371

[115] Zhao S,Zhang L.Clinicopathological and prognostic significance of regulatory T cells in patients with non-small cell lung cancer: a systematic review with meta-analysis.Oncotarget2016;7:36065-73 PMCID:PMC5094983

[116] Maeda Y,Sugiyama D.Detection of self-reactive CD8⁺ T cells with an anergic phenotype in healthy individuals.Science2014;346:1536-40

[117] Pollack SM,Yearley JH.T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.Cancer2017;123:3291-304 PMCID:PMC5568958

[118] Zhang S,Sedgwick JD.Molecular mechanisms of CD200 inhibition of mast cell activation.J Immunol2004;173:6786-93

[119] Su Y,Morisue R.Tumor-infiltrating T cells concurrently overexpress CD200R with immune checkpoints PD-1, CTLA-4, and TIM-3 in non-small-cell lung cancer.Pathobiology2021;88:218-27

[120] Tucker RP.Revisiting the tenascins: exploitable as cancer targets?.Front Oncol2022;12:908247 PMCID:PMC9248440

[121] Bonnans C,Werb Z.Remodelling the extracellular matrix in development and disease.Nat Rev Mol Cell Biol2014;15:786-801 PMCID:PMC4316204

[122] Donovan C,Chan YL.Tenascin C in lung diseases.Biology2023;12:199 PMCID:PMC9953172

[123] Okada T.The role of tenascin-C in tissue injury and repair after stroke.Front Immunol2020;11:607587 PMCID:PMC7859104

[124] Radwanska A,Schaub S.Counterbalancing anti-adhesive effects of tenascin-C through fibronectin expression in endothelial cells.Sci Rep2017;7:12762 PMCID:PMC5630602

[125] Geleta B,Lim SC.Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1.J Biol Chem2022;298:101608 PMCID:PMC8881656

[126] Gocheva V,Bhutkar A.Quantitative proteomics identify tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival.Proc Natl Acad Sci U S A2017;114:E5625-34 PMCID:PMC5514763

[127] Tang YA,Sun HS.Global Oct4 target gene analysis reveals novel downstream PTEN and TNC genes required for drug-resistance and metastasis in lung cancer.Nucleic Acids Res2015;43:1593-608 PMCID:PMC4330385

[128] Gebauer F,Zander H.Tenascin-C serum levels and its prognostic power in non-small cell lung cancer.Oncotarget2016;7:20945-52 PMCID:PMC4991503

[129] Ishiwata T,Shimanuki Y.Serum tenascin-C as a potential predictive marker of angiogenesis in non-small cell lung cancer.Anticancer Res2005;25:489-95

[130] Huang JY,Lin YP.Extracellular matrix of glioblastoma inhibits polarization and transmigration of T cells: the role of tenascin-C in immune suppression.J Immunol2010;185:1450-9

[131] Onion D,Shridhar N.Multicomponent analysis of the tumour microenvironment reveals low CD8 T cell number, low stromal caveolin-1 and high tenascin-C and their combination as significant prognostic markers in non-small cell lung cancer.Oncotarget2018;9:1760-71 PMCID:PMC5788597

[132] Raudenska M,Balvan J.Caveolin-1 in oncogenic metabolic symbiosis.Int J Cancer2020;147:1793-807

[133] Zhao X,Gao J.Caveolin-1 expression level in cancer associated fibroblasts predicts outcome in gastric cancer.PLoS One2013;8:e59102 PMCID:PMC3602462

[134] Luan TY,Cui YJ.Expression of caveolin-1 is correlated with lung adenocarcinoma proliferation, migration, and invasion.Med Oncol2015;32:207

[135] Ho CC,Huang PH,Yang CH.Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy.Lung Cancer2008;59:105-10

[136] Zhan P,Qian Q.Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas.Oncol Rep2012;27:1072-8 PMCID:PMC3583595

[137] Bertino EM,Nana-Sinkam SP.Stromal caveolin-1 is associated with response and survival in a phase II trial of nab-paclitaxel with carboplatin for advanced NSCLC patients.Clin Lung Cancer2015;16:466-74 PMCID:PMC5076571

[138] González-González L.Periostin: a matricellular protein with multiple functions in cancer development and progression.Front Oncol2018;8:225 PMCID:PMC6005831

[139] O’Dwyer DN.The role of periostin in lung fibrosis and airway remodeling.Cell Mol Life Sci2017;74:4305-14 PMCID:PMC5659879

[140] Naik PK, Bozyk PD, Bentley JK, et al; COMET Investigators. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2012;303:L1046-56. PMCID:PMC3532583

[141] Ratajczak-Wielgomas K,Grzegrzołka J.Prognostic significance of stromal periostin expression in non-small cell lung cancer.Int J Mol Sci2020;21:7025 PMCID:PMC7582720

[142] Yoshihara T,Nunomura S.Periostin plays a critical role in the cell cycle in lung fibroblasts.Respir Res2020;21:38 PMCID:PMC6993476

[143] Ouyang G,Ruan K,Mao Y.Upregulated expression of periostin by hypoxia in non-small-cell lung cancer cells promotes cell survival via the Akt/PKB pathway.Cancer Lett2009;281:213-9

[144] Shochet G, Brook E, Bardenstein-Wald B, Shitrit D. TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling.Respir Res2020;21:56 PMCID:PMC7029598

[145] Chen X,Cao H.The hedgehog and Wnt/β-catenin system machinery mediate myofibroblast differentiation of LR-MSCs in pulmonary fibrogenesis.Cell Death Dis2018;9:639 PMCID:PMC5974360

[146] Yamato H,Fukui E.Periostin secreted by activated fibroblasts in idiopathic pulmonary fibrosis promotes tumorigenesis of non-small cell lung cancer.Sci Rep2021;11:21114 PMCID:PMC8548404

[147] Reck M, Kaiser R, Mellemgaard A, et al; LUME-Lung 1 Study Group. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial. Lancet Oncol 2014;15:143-55.

[148] Richeldi L, du Bois RM, Raghu G, et al; INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2071-82.

[149] Kato R,Hayashi H.Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated fibroblasts.Br J Cancer2021;124:914-24 PMCID:PMC7921555

[150] Kim D,Cheon I.Identification and characterization of cancer-associated fibroblast subpopulations in lung adenocarcinoma.Cancers2022;14:3486 PMCID:PMC9324153

[151] Hu H,Hare PJ.Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms.Cancer Cell2021;39:1531-47.e10 PMCID:PMC8578451

[152] Lambrechts D,Boeckx B.Phenotype molding of stromal cells in the lung tumor microenvironment.Nat Med2018;24:1277-89

[153] Zhao X,Chen H.Autophagic tumor stroma: mechanisms and roles in tumor growth and progression.Int J Cancer2013;132:1-8

[154] Zhang D,Li Y.Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells.Sci Rep2017;7:16231 PMCID:PMC5701200

[155] Leung CS,Yip KP.Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.J Clin Invest2018;128:589-606 PMCID:PMC5785271

[156] Li Z,Qi Y.Participation of CCL1 in snail-positive fibroblasts in colorectal cancer contribute to 5-fluorouracil/paclitaxel chemoresistance.Cancer Res Treat2018;50:894-907 PMCID:PMC6056976

[157] Wei L,Li G.Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer.Cell Death Dis2018;9:1065 PMCID:PMC6194073

[158] Wang L,Cui JY,Chen YT.CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway.Oncol Rep2018;39:2081-90 PMCID:PMC5928760

[159] Blanco-Gómez A,Corchado-Cobos R.Stromal SNAI2 is required for ERBB2 breast cancer progression.Cancer Res2020;80:5216-30 PMCID:PMC7718390

[160] Li J,Long X,Xiang X.mir-1-mediated paracrine effect of cancer-associated fibroblasts on lung cancer cell proliferation and chemoresistance.Oncol Rep2016;35:3523-31

[161] Yi Y,Wang Z.Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF/IGF-1/ANXA2 signaling.Biochim Biophys Acta Mol Basis Dis2018;1864:793-803

[162] Zhou B,Li N.Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways.Int J Oncol2016;48:2087-97

[163] Quante M,Tomita H.Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth.Cancer Cell2011;19:257-72 PMCID:PMC3060401

[164] Lotti F,Pai RK.Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A.J Exp Med2013;210:2851-72 PMCID:PMC3865474

[165] Butti R,Kumar TVS,Kundu GC.Breast cancer stem cells: Biology and therapeutic implications.Int J Biochem Cell Biol2019;107:38-52

[166] Vermeulen L,van der Heijden M.Wnt activity defines colon cancer stem cells and is regulated by the microenvironment.Nat Cell Biol2010;12:468-76

[167] Bu L,Yasuda T,Ishimoto T.Functional diversity of cancer-associated fibroblasts in modulating drug resistance.Cancer Sci2020;111:3468-77 PMCID:PMC7541012

[168] Yu T,Hou Y.Cytoplasmic GPER translocation in cancer-associated fibroblasts mediates cAMP/PKA/CREB/glycolytic axis to confer tumor cells with multidrug resistance.Oncogene2017;36:2131-45

[169] Apicella M,Fiore S.Increased lactate secretion by cancer cells sustains non-cell-autonomous adaptive resistance to MET and EGFR targeted therapies.Cell Metab2018;28:848-65.e6

[170] Vukovic V.Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan.Br J Cancer1997;75:1167-72 PMCID:PMC2222779

[171] Bartrons R,Rodríguez-García A.Fructose 2,6-bisphosphate in cancer cell metabolism.Front Oncol2018;8:331 PMCID:PMC6131595

[172] Semenza G.Signal transduction to hypoxia-inducible factor 1.Biochem Pharmacol2002;64:993-8

[173] Hu Y,Huang H.Recent agents targeting HIF-1α for cancer therapy.J Cell Biochem2013;114:498-509

[174] Glentis A,Mariani P.Cancer-associated fibroblasts induce metalloprotease-independent cancer cell invasion of the basement membrane.Nat Commun2017;8:924 PMCID:PMC5640679

[175] Soysal SD,Muenst SE.Role of the tumor microenvironment in breast cancer.Pathobiology2015;82:142-52

[176] Gonzalez-Avila G,Mendoza-Posada DA,Garcia-Hernandez AA.Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer.Crit Rev Oncol Hematol2019;137:57-83

[177] Hao J,Pintilie M.Characterization of distinct populations of carcinoma-associated fibroblasts from non-small cell lung carcinoma reveals a role for ST8SIA2 in cancer cell invasion.Neoplasia2019;21:482-93 PMCID:PMC6458340

[178] Joyce MH,James ER.Phenotypic basis for matrix stiffness-dependent chemoresistance of breast cancer cells to doxorubicin.Front Oncol2018;8:337 PMCID:PMC6134055

[179] Li X,Yu X,Huang G.Reverse of microtubule-directed chemotherapeutic drugs resistance induced by cancer-associated fibroblasts in breast cancer.Onco Targets Ther2019;12:7963-73 PMCID:PMC6773970

[180] Folgueira MAAK,Katayama MLH.Markers of breast cancer stromal fibroblasts in the primary tumour site associated with lymph node metastasis: a systematic review including our case series.Biosci Rep2013;33:e00085 PMCID:PMC3860578

[181] Ishii G,Neri S.Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment.Adv Drug Deliv Rev2016;99:186-96

[182] Pontiggia O,Raffo D.The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin.Breast Cancer Res Treat2012;133:459-71 PMCID:PMC3719875

[183] Howlader N,Mooradian MJ.The effect of advances in lung-cancer treatment on population mortality.N Engl J Med2020;383:640-9 PMCID:PMC8577315

[184] Bughda R,D’Souza RR.Fibroblast activation protein (FAP)-targeted CAR-T cells: launching an attack on tumor stroma.Immunotargets Ther2021;10:313-23 PMCID:PMC8354246

[185] Shintani Y,Kimura T.IL-6 secreted from cancer-associated fibroblasts mediates chemoresistance in NSCLC by increasing epithelial-mesenchymal transition signaling.J Thorac Oncol2016;11:1482-92

[186] Han C,Yin R.Biomarkers for cancer-associated fibroblasts.Biomark Res2020;8:64 PMCID:PMC7661188

[187] Qu J,Liu L,Chen L.Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.Cancer Commun2021;41:1331-53 PMCID:PMC8696219

[188] Nakamura H,Miyashita T.Organoid culture containing cancer cells and stromal cells reveals that podoplanin-positive cancer-associated fibroblasts enhance proliferation of lung cancer cells.Lung Cancer2019;134:100-7

[189] Dominguez CX,Keerthivasan S.Single-cell RNA sequencing reveals stromal evolution into LRRC15⁺ myofibroblasts as a determinant of patient response to cancer immunotherapy.Cancer Discov2020;10:232-53

[190] Mahmoudi S,Xu L.Heterogeneity in old fibroblasts is linked to variability in reprogramming and wound healing.Nature2019;574:553-8 PMCID:PMC7253295

[191] LeBleu VS.A peek into cancer-associated fibroblasts: origins, functions and translational impact.Dis Model Mech2018;11:dmm029447 PMCID:PMC5963854

[192] Kalluri R.Fibroblasts in cancer.Nat Rev Cancer2006;6:392-401

[193] Laughney AM,Campbell NR.Regenerative lineages and immune-mediated pruning in lung cancer metastasis.Nat Med2020;26:259-69 PMCID:PMC7021003

[194] Maynard A,Rotow JK.Therapy-induced evolution of human lung cancer revealed by single-cell RNA sequencing.Cell2020;182:1232-51.e22 PMCID:PMC7484178

[195] Lawson WE,Zoia O.Characterization of fibroblast-specific protein 1 in pulmonary fibrosis.Am J Respir Crit Care Med2005;171:899-907

[196] Lyu P,Wang F.Advances in targeting cancer-associated fibroblasts through single-cell spatial transcriptomic sequencing.Biomark Res2024;12:73 PMCID:PMC11287900

[197] Meng J,Wan C.Targeting senescence-like fibroblasts radiosensitizes non-small cell lung cancer and reduces radiation-induced pulmonary fibrosis.JCI Insight2021;6:e146334 PMCID:PMC8675198